Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Placebo-Controlled Trial of Metformin in Individuals With Fragile X Syndrome (FXS)

NCT03862950 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT03862950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03862950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Placebo-Controlled Trial of Metformin in Individuals With Fragile X Syndrome (FXS)
Lead sponsor
University of Alberta
Phase
Phase 2
Overall status
Completed
Start date
May 24, 2019
Completion date
December 16, 2025
Enrollment
125 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fra(x) syndrome, fragile x mental retardation syndrome, fragile x syndrome, fxs, genetic diseases, x-linked, intellectual disability, mental retardation, x-linked, neurobehavioral manifestations, sex chromosome disorders, trinucleotide repeat expansion